These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 1850473)

  • 21. Platelet-activating factor stimulates arachidonic acid metabolism in rat liver cells (C-9 cell line) by a receptor-mediated mechanism.
    Levine L
    Mol Pharmacol; 1988 Dec; 34(6):793-9. PubMed ID: 2849046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
    Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
    Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamics, pharmacokinetics and safety profile of the new platelet-activating factor antagonist apafant in man.
    Brecht HM; Adamus WS; Heuer HO; Birke FW; Kempe ER
    Arzneimittelforschung; 1991 Jan; 41(1):51-9. PubMed ID: 1646613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
    Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
    J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.
    Giembycz MA; Kroegel C; Barnes PJ
    J Immunol; 1990 May; 144(9):3489-97. PubMed ID: 2158510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
    Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
    Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-activating factor induction of secreted phosphatase activity in Trypanosoma cruzi.
    Rodrigues CO; Dutra PM; Barros FS; Souto-Padrón T; Meyer-Fernandes JR; Lopes AH
    Biochem Biophys Res Commun; 1999 Dec; 266(1):36-42. PubMed ID: 10581161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular mechanisms of hydrogen peroxide-mediated neutrophil adherence to cultured human endothelial cells.
    Okayama N; Coe L; Oshima T; Itoh M; Alexander JS
    Microvasc Res; 1999 Mar; 57(2):63-74. PubMed ID: 10049654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor.
    Kassuya CA; Silvestre A; Menezes-de-Lima O; Marotta DM; Rehder VL; Calixto JB
    Eur J Pharmacol; 2006 Sep; 546(1-3):182-8. PubMed ID: 16925995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel effect of Y-24180, a presumed specific platelet activation factor receptor antagonist, on Ca2+ levels and growth of human prostate cancer cells.
    Jan CR; Chao YY
    Cell Signal; 2004 Aug; 16(8):959-65. PubMed ID: 15157675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L; Floch A; Mondot S; Cavero I
    Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
    Shukla SD; Morrison WJ; Dhar A
    Mol Pharmacol; 1989 Apr; 35(4):409-13. PubMed ID: 2539556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
    Ammit AJ; O'Neill C
    Lipids; 1991 Dec; 26(12):1189-92. PubMed ID: 1668116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
    Rabinovici R; Yue TL; Farhat M; Smith EF; Esser KM; Slivjak M; Feuerstein G
    J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of large conductance Ca(2+)-activated K+ channels in N1E-115 neuroblastoma cells by platelet-activating factor.
    Diserbo M; Fatôme M; Verdetti J
    Biochem Biophys Res Commun; 1996 Jan; 218(3):745-8. PubMed ID: 8579584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
    Dive C; Watson JV; Workman P
    Cancer Res; 1991 Feb; 51(3):799-806. PubMed ID: 1988120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor induces enhanced responses to platelet-activating factor and differentiation in human monocytic Mono Mac 6 cells.
    Weber C; Aepfelbacher M; Haag H; Ziegler-Heitbrock HW; Weber PC
    Eur J Immunol; 1993 Apr; 23(4):852-9. PubMed ID: 7681399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hetrazepine PAF antagonists.
    Ikegami K; Meade CJ; Heuer HO; Birke F
    J Lipid Mediat; 1992; 5(2):177-82. PubMed ID: 1326346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and cellular actions of platelet-activating factor in rat heart cells.
    Massey CV; Kohout TA; Gaa ST; Lederer WJ; Rogers TB
    J Clin Invest; 1991 Dec; 88(6):2106-16. PubMed ID: 1661298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
    Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T
    Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.